ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Surveillance Treatment Option For Low-Risk Prostate Cancer

July 30, 2010

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

Myriad In Partnership To Market Products.

December 14, 2001

NCI Appropriations, Authorization Bills Passed By House

September 5, 1980

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976

NCI-Approved Clinical Trials

January 26, 2007